MET Gene Status in Malignant Mesothelioma Using Fluorescent In Situ Hybridization

J Thorac Oncol. 2016 Feb;11(2):e28-30. doi: 10.1016/j.jtho.2015.10.019.

Authors

Serena Varesano¹, Sandra Salvi¹, Simona Boccardo¹, Jean Louis Ravetti¹, Maria Pia Pistillo², Pier Aldo Canessa³, Paola Ferro⁴, Franco Fedeli⁴, Silvio Roncella⁵

Affiliations

¹ Division of Histopathology and Cytopathology, IRCCS A.O.U. San Martino-IST, Genova, Italy.
² Unit of Tumor Epigenetics, IRCCS A.O.U. San Martino-IST, Genova, Italy.
³ Division of Pneumology, ASL5, La Spezia, Italy.
⁴ Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy.
⁵ Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy. Electronic address: Silvio.roncella@asl5.liguria.it.

PMID: 26811229
DOI: 10.1016/j.jtho.2015.10.019

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
In Situ Hybridization
In Situ Hybridization, Fluorescence*
Lung Neoplasms / genetics*
Mesothelioma
Pleural Neoplasms